Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
screening
MedTech
Freenome to go public in $330M SPAC deal
Backed by an affiliate of Perceptive Advisors and joined by RA Capital, the move includes a commitment of $240 million in equity investments.
Conor Hale
Dec 5, 2025 10:35am
Abbott inks $23B deal for Exact Sciences in cancer testing buy
Nov 20, 2025 10:30am
PacBio launches carrier screening panel in reproductive health
Sep 22, 2025 11:00am
Exact Sciences rolls out Cancerguard multi-cancer blood test
Sep 11, 2025 1:00pm
Grail plans to submit updated Galleri blood test to FDA in 2026
Jun 18, 2025 11:45am
Quest Diagnostics taps MD Anderson for cancer risk blood test
Jun 10, 2025 2:11pm
